Mather, R.J.
AstraZeneca (United States)
2 papers on CoChatORCID 0000-0001-9105-7798
Most cited papers
- Verified
Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid
Rollema, H., Chambers, L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C., et al. (2007) · Neuropharmacology
Nicotinic Acetylcholine Receptors StudySmoking Behavior and Cessation
Cited by 533
- Verified
The CHRNA5–A3–B4 Gene Cluster and Smoking: From Discovery to Therapeutics
Lassi, G., Taylor, A. E., Timpson, N. J., Kenny, P. J., Mather, R. J., Eisen, T., & Munafò, M. R. (2016) · Trends in Neurosciences
Smoking Behavior and CessationNicotinic Acetylcholine Receptors Study
Cited by 85
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free